IL6 and hepatocellular carcinoma: In order to validate an altered IL-6/STAT3 axis as well as FXR deficiency in HCC cells, the gene expression of IL-1β, IL-6, STAT3, & FXR was assessed in normal liver cells and compared to expression levels in HepG2 and Huh7 cells.